Discover the detailed record of transactions filed by Cunningham David, Director. Insider active across 1 company, notably Immucell CORP. Aggregated, 1 filings have been logged. Split: 1 buy · 0 sell. Total volume traded: €8k. History available since 13 June 2022. The latest transaction was disclosed on 13 June 2022 (Acquisition). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration
David Cunningham is a Board Member at ImmunoCell Corp. He contributes to the strategic direction of the company, which focuses on immunological solutions. His expertise in the sector is crucial in guiding strategic decisions and supporting innovation.